Skip to content

Satiating Effects of Isolated Soy Proteins

Comparison of the Satiating Effects of Differentially Processed Isolated Soy Proteins

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01731197
Enrollment
40
Registered
2012-11-21
Start date
2012-11-30
Completion date
2013-11-30
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Management

Keywords

obesity, isolated soy protein, satiety, food intake

Brief summary

Proteins are known to be more satiating than the other macronutrients; however, the type and amount of protein needed to induce a significant effect on satiety (fullness between meals) is sometimes difficult to determine. In this study, 2 differentially processed isolated soy proteins will be tested for satiety using subjective visual analogue scales. The amount of food consumed following intake of the isolated soy proteins will be measured 3 hours after consuming the proteins. The hypothesis is that differentially processed isolated soy proteins will show unique satiety responses.

Interventions

DIETARY_SUPPLEMENTDry-Blended Beverage

Sponsors

DuPont Nutrition and Health
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 20 and 30 kg/m2 * Age between 18-65y * Unrestrained eater (score\<12) * Regularly consume 3 meals per day * Moderate exercise (eg running, aerobics classes, other sports activities) of no more than 7 hours per week

Exclusion criteria

* use of drugs that influence carbohydrate or lipid metabolism (eg. hypoglycemic agents, antibiotics taken less than 6 weeks before study entry, glucocorticoids, anti-diarrheal medication, weight loss medication, and anti-diabetic medication) * presence of any significant disease (eg gastrointestinal diseases, diabetes, a CVD event less than 12 weeks from study entry, current hepatic disease, etc) * use of special dietary treatments within 4 weeks of study (eg weight loss diet, extremely high or low carbohydrate/protein/fat diet, use of meal replacements more than once a day) * use of supplements within 1 week of study (does not include vitamin supplements or supplements which are routinely taken and were initiated 4 weeks before the study and which will be continued during the study period) * restrained eater (score\>12) * weight change (absolute body weight change of ≥ 10%) within the previous 6 weeks * alcohol intake \>2 drinks/day * food allergies of any kind * swallowing difficulties * exercising more than 7 hours per week

Design outcomes

Primary

MeasureTime frameDescription
Subjective Satiety3 hoursMeasure subjective satiety using visual analogue scales

Secondary

MeasureTime frameDescription
Ad Libitum Food Intake30 minutesAt the end of 3 hours after consuming test diets, measure the amount of food consumed for 30 mins

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026